We will get a full plan from our new President, there is nothing indicating we won’t. These last 7 months have been all part of making CytoDyn a normal responsible company, back from the crazy days of the Pandemic. The share price is just normalizing back to the March 2020 place before all the attacks, about 2.20-2.60 so dilution should put us at 1.45. If we have a success and are still going it alone expect to get hammered and attacked again like Novavax since its EUA.

The Pandemic was good for us for two reasons. Our trails opened up a whole bunch of possible new indications for Leronlimab and it showed us just corrupt the entire approval system is. But now is a time to move on with our new knowledge to say that was then and this is now.